Lenvatinib is used in the treatment of thyroid cancer.
Lenvatinib is also utilised as a first-line treatment for advanced renal cell carcinoma, alongside pembrolizumab. Lenvatinib is also used to treat hepatocellular carcinoma, a type of endometrial cancer that has progressed to other parts of the body, has worsened during or after chemotherapy treatment, and cannot be cured with surgery or radiation therapy.
The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you.